Compare · EAR vs ELV
EAR vs ELV
Side-by-side comparison of Eargo Inc. (EAR) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EAR and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.81B, about 508.3x EAR ($178.6M).
- ELV has hit the wire 3 times in the past 4 weeks while EAR has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 3 for EAR).
- Company
- Eargo Inc.
- Elevance Health Inc.
- Price
- $2.57-2.28%
- $418.31+0.63%
- Market cap
- $178.6M
- $90.81B
- 1M return
- -
- +12.19%
- 1Y return
- -
- +7.35%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 3
- Recent ratings
- 3
- 23
Eargo Inc.
Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest EAR
- SEC Form 15-12G filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- SEC Form S-8 POS filed by Eargo Inc.
- Brownie William returned 296 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Narula Onkarr
- Wu David James returned 25,463 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Sabet-Peyman Afshin Justin
- SEC Form 4 filed by Bayne Katie J
- SEC Form 4 filed by Spence Donald J
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)